• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体成分 C5a 存在于人体冠状动脉病变中,并在体外诱导人巨噬细胞表达 MMP-1 和 MMP-9。

The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro.

机构信息

Department of Internal Medicine II, University of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria.

出版信息

FASEB J. 2011 Jan;25(1):35-44. doi: 10.1096/fj.10-156083. Epub 2010 Sep 2.

DOI:10.1096/fj.10-156083
PMID:20813982
Abstract

The complement component C5a is formed during activation of the complement cascade and exerts chemotactic and proinflammatory effects. Macrophages, which are localized in the rupture-prone shoulder regions of coronary plaques, are thought to play a major role in plaque destabilization and rupture through the production of matrix metalloproteinases (MMPs). When human monocyte-derived macrophages were stimulated in vitro with C5a, MMP-1 and MMP-9 mRNA levels were significantly increased. Furthermore, C5a up-regulated MMP-1 and MMP-9 antigens and activity, as determined by ELISA and specific activity assays. These effects were blocked by antibodies against the receptor C5aR/CD88. In addition, blocking experiments revealed that MMP-1 expression was mediated by activation of the transcription factor AP-1, and MMP-9 expression was induced by activation of NF-κB and AP-1. Immunohistochemical analysis of human coronary plaques demonstrated the colocalization of C5a, MMP-1, and MMP-9 in vivo. Together, these observations indicate that activation of the complement cascade and formation of C5a may play a role in the onset of acute coronary events by induction of MMPs in atherosclerotic lesions.

摘要

补体成分 C5a 在补体级联激活过程中形成,并发挥趋化和促炎作用。巨噬细胞定位于易破裂的冠状动脉斑块肩部区域,通过产生基质金属蛋白酶 (MMPs) 被认为在斑块不稳定和破裂中起主要作用。当体外用人单核细胞衍生的巨噬细胞用 C5a 刺激时,MMP-1 和 MMP-9 mRNA 水平显著增加。此外,通过 ELISA 和特定活性测定法确定,C5a 上调了 MMP-1 和 MMP-9 抗原和活性。这些作用被针对受体 C5aR/CD88 的抗体阻断。此外,阻断实验表明 MMP-1 表达是通过转录因子 AP-1 的激活介导的,而 MMP-9 表达是通过 NF-κB 和 AP-1 的激活诱导的。对人类冠状动脉斑块的免疫组织化学分析表明,C5a、MMP-1 和 MMP-9 在体内共定位。总之,这些观察结果表明,补体级联的激活和 C5a 的形成可能通过在动脉粥样硬化病变中诱导 MMPs 而在急性冠状动脉事件的发生中起作用。

相似文献

1
The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro.补体成分 C5a 存在于人体冠状动脉病变中,并在体外诱导人巨噬细胞表达 MMP-1 和 MMP-9。
FASEB J. 2011 Jan;25(1):35-44. doi: 10.1096/fj.10-156083. Epub 2010 Sep 2.
2
In human macrophages the complement component C5a induces the expression of oncostatin M via AP-1 activation.在人类巨噬细胞中,补体成分C5a通过激活AP-1诱导制瘤素M的表达。
Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):498-503. doi: 10.1161/ATVBAHA.107.160580. Epub 2008 Jan 10.
3
Plaque oxysterols induce unbalanced up-regulation of matrix metalloproteinase-9 in macrophagic cells through redox-sensitive signaling pathways: Implications regarding the vulnerability of atherosclerotic lesions.斑块氧化固醇通过氧化还原敏感信号通路诱导巨噬细胞中基质金属蛋白酶-9 的不平衡上调:与动脉粥样硬化病变易损性相关的意义。
Free Radic Biol Med. 2011 Aug 15;51(4):844-55. doi: 10.1016/j.freeradbiomed.2011.05.030. Epub 2011 May 30.
4
The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-kappaB activation.补体成分C5a通过激活核因子κB诱导人巨噬细胞中纤溶酶原激活物抑制剂-1的表达。
J Thromb Haemost. 2006 Aug;4(8):1790-7. doi: 10.1111/j.1538-7836.2006.02046.x.
5
Catecholamines potentiate LPS-induced expression of MMP-1 and MMP-9 in human monocytes and in the human monocytic cell line U937: possible implications for peri-operative plaque instability.儿茶酚胺增强脂多糖诱导的人单核细胞和人单核细胞系U937中基质金属蛋白酶-1(MMP-1)和基质金属蛋白酶-9(MMP-9)的表达:对围手术期斑块不稳定的可能影响。
FASEB J. 2004 Mar;18(3):603-5. doi: 10.1096/fj.03-0454fje. Epub 2004 Jan 8.
6
Receptors for the anaphylatoxin C5a (CD88) on human mesangial cells.人系膜细胞上过敏毒素C5a(CD88)的受体。
J Immunol. 1998 Jun 1;160(11):5646-52.
7
C5a receptor and interleukin-6 are expressed in tissue macrophages and stimulated keratinocytes but not in pulmonary and intestinal epithelial cells.C5a受体和白细胞介素-6在组织巨噬细胞和受刺激的角质形成细胞中表达,但在肺和肠上皮细胞中不表达。
Am J Pathol. 1999 Feb;154(2):495-501. doi: 10.1016/S0002-9440(10)65295-9.
8
Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.人参皂苷Rh2对人星形胶质瘤细胞基质金属蛋白酶基因表达的抑制作用
Biochem Pharmacol. 2007 Dec 3;74(11):1642-51. doi: 10.1016/j.bcp.2007.08.015. Epub 2007 Aug 19.
9
Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.白细胞介素-1上调单核细胞上的过敏毒素受体。
Surgery. 2004 May;135(5):544-54. doi: 10.1016/j.surg.2003.09.010.
10
Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque.基质金属蛋白酶9及其调节因子在不稳定型冠状动脉粥样硬化斑块中的表达
Int J Mol Med. 2005 Jan;15(1):57-65.

引用本文的文献

1
Enigmatic Roles of Complement Anaphylatoxin Signaling in Health and Disease.补体过敏毒素信号在健康与疾病中的神秘作用
Immune Netw. 2025 Aug 20;25(4):e32. doi: 10.4110/in.2025.25.e32. eCollection 2025 Aug.
2
Novel Tear Biomarkers in Ocular Graft Versus Host Disease Associated with Th1/Th2 Immune Responses: A Case Series and Literature Review.与Th1/Th2免疫反应相关的眼部移植物抗宿主病中的新型泪液生物标志物:病例系列及文献综述
Int J Mol Sci. 2025 May 1;26(9):4311. doi: 10.3390/ijms26094311.
3
Inflammatory Pathways in Coronary Artery Disease: Which Ones to Target for Secondary Prevention?
冠状动脉疾病中的炎症通路:二级预防应针对哪些通路?
Cells. 2025 Jan 21;14(3):153. doi: 10.3390/cells14030153.
4
Genetic association with autoimmune diseases identifies molecular mechanisms of coronary artery disease.与自身免疫性疾病的基因关联确定了冠状动脉疾病的分子机制。
iScience. 2024 Aug 13;27(9):110715. doi: 10.1016/j.isci.2024.110715. eCollection 2024 Sep 20.
5
The tumor immune microenvironment and T-cell-related immunotherapies in colorectal cancer.结直肠癌中的肿瘤免疫微环境与T细胞相关免疫疗法
Discov Oncol. 2024 Jun 25;15(1):244. doi: 10.1007/s12672-024-01117-7.
6
The Role of Bacterial Extracellular Membrane Nanovesicles in Atherosclerosis: Unraveling a Potential Trigger.细菌细胞外膜纳米囊泡在动脉粥样硬化中的作用:揭示一个潜在的触发因素。
Curr Atheroscler Rep. 2024 Jul;26(7):289-304. doi: 10.1007/s11883-024-01206-6. Epub 2024 May 28.
7
Canonical and non-canonical roles of complement in atherosclerosis.补体在动脉粥样硬化中的经典和非经典作用。
Nat Rev Cardiol. 2024 Nov;21(11):743-761. doi: 10.1038/s41569-024-01016-y. Epub 2024 Apr 10.
8
Heparin-Mediated Extracorporeal Low-Density Lipoprotein Precipitation Apheresis for Treating Peripheral Arterial Disease in Patients with Chronic Kidney Disease.肝素介导的体外低密度脂蛋白沉淀单采术治疗慢性肾脏病患者的外周动脉疾病
J Clin Med. 2024 Feb 16;13(4):1121. doi: 10.3390/jcm13041121.
9
New insight of complement system in the process of vascular calcification.补体系统在血管钙化过程中的新认识。
J Cell Mol Med. 2023 May;27(9):1168-1178. doi: 10.1111/jcmm.17732. Epub 2023 Apr 1.
10
regulates atherosclerosis through an immune pathway.通过免疫途径调节动脉粥样硬化。
Front Immunol. 2023 Mar 14;14:1103592. doi: 10.3389/fimmu.2023.1103592. eCollection 2023.